A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657

Autor: Sohal, Jastinder, Phan, Vernon T., Chan, Philip V., Davis, Elizabeth M., Patel, Bhumi, Kelly, Louise M., Abrams, Tinya J., O’Farrell, Anne Marie, Gilliland, D. Gary, Le Beau, Michelle M., Kogan, Scott C. *
Zdroj: In Blood 15 April 2003 101(8):3188-3197
Databáze: ScienceDirect